Evidence map›Paper›PMID 29917118›Full record

ReviewNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2019

Considering Systemic Barriers to Treating Tobacco Use in Clinical Settings in the United States.

Alana M Rojewski, Steffani R Bailey, Steven L Bernstein, Nina A Cooperman, Ellen R Gritz, Maher A Karam-Hage, Megan E Piper, Nancy A Rigotti, Graham W Warren

Open access · bronzeAbstract readReview
In one paragraph

Review in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 85 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Schools' Readiness for Child Sexual Abuse Prevention Education: an Overview of Theoretical Models.Prevention science : the official journal of the Society for Prevention Research · 2025
    Review
  10. Article
  11. Updates in Lung Cancer Screening: A Decade of Evidence.Seminars in respiratory and critical care medicine · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 1 country.

Alana M RojewskiDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, SC.
Steffani R BaileyDepartment of Family Medicine, Oregon Health and Science University, Portland, OR.
Steven L BernsteinDepartment of Emergency Medicine, Yale School of Medicine, New Haven, CT.
Nina A CoopermanDepartment of Psychiatry, Rutgers Robert Wood Johnson Medical School, Piscataway, NJ.
Ellen R GritzDepartment of Behavioral Science, University of Texas MD Anderson Cancer Center, Houston, TX.
Maher A Karam-HageDepartment of Behavioral Science, University of Texas MD Anderson Cancer Center, Houston, TX.
Megan E PiperCenter for Tobacco Research and Intervention, School of Medicine and Public Health, University of Wisconsin, Madison, WI.
Nancy A RigottiDepartment of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
Graham W WarrenDepartment of Radiation Oncology, Medical University of South Carolina, Charleston, SC.
Medical University of South Carolina · USThe University of Texas MD Anderson Cancer Center · USHarvard University · USOregon Health & Science University · USRutgers Cancer Institute of New JerseyUniversity of Wisconsin–Madison · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Western States Node of the National Drug Abuse Treatment Clinical Trials Network (TMS for CUD) UG1DA015815 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Keith N. Humphreys, Philip Todd Korthuis · 2015 to 2026
$24.6M
NCATS NIH HHS UL1 TR001863NIDA NIH HHS UG1 DA015815
6 · The paper itself

Abstract

The Comorbidity Workgroup of the Tobacco Treatment Research Network, within the Society for Research on Nicotine and Tobacco, previously highlighted the need to provide tobacco treatment to patients diagnosed with comorbid physical and mental health conditions. Yet, systemic barriers in the United States health care system prevent many patients who present for medical treatment from getting the evidence-based tobacco treatment that they need. The identified barriers include insufficient training in the epidemiologic impact of tobacco use, related disorders, and pharmacological and behavioral treatment approaches; misunderstanding among clinicians about the effectiveness of tobacco treatment; lack of therapeutic support from clinical staff; insufficient use of health information technology to improve tobacco use identification and treatment; and limited time and reimbursement for clinicians to provide treatment. We highlight three vignettes demonstrating the complexities of practical barriers at the health care system level. We consider each of the barriers in turn and discuss evidence-based strategies that could be implemented in the clinical care of patients with comorbid conditions. In addition, in the absence of compelling data to guide implementation approaches, we offer suggestions for potential strategies and avenues for future research. Implications: Three vignettes highlighted in this article illustrate some systemic barriers to providing tobacco treatment for patients being treated for comorbid conditions. We explore the barriers to tobacco treatment and offer suggestions for changes in training, health care systems, clinical workflow, and payment systems that could enhance the reach and the quality of tobacco treatment within the US health care system.

Indexed as

Communication BarriersComorbidityHumansSmoking CessationTobacco Use DisorderUnited States

Identifiers

PMID29917118
PMCPMC6941704
OpenAlexW2809650263

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.